Viewing nowHuinies Atorvastatin Calcium Tablet 10mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Huinus Meditech Co., Ltd.

MFDS item code 201502561 · Approved 2015.04.28 · Insurance code 670400770
Improvement of hyperlipidemia in adults and children, and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction, stroke, and angina in adults with various risk factors for coronary heart disease and patients with type 2 diabetes. It is also effective in reducing the risk of non-fatal myocardial infarction and stroke, managing post-angioplasty, and decreasing the risk of hospitalization due to congestive heart failure. In the treatment of hyperlipidemia, it lowers the levels of LDL cholesterol, total cholesterol, and triglycerides while increasing HDL cholesterol levels, thereby improving health. It is also used in the treatment of familial hypercholesterolemia in pediatric patients, contributing to lowering cholesterol levels. Thus, it is effectively used to improve cardiovascular health.
Patients receiving or about to receive atorvastatin should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients who require greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and in assessing response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg/day of this medicine, and the recommended maximum dose is 20 mg/day (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms; therefore, if symptoms such as myalgia, muscle weakness, or muscle cramps occur, notify your doctor immediately and discontinue treatment. This medication should not be used in individuals with certain liver diseases, pregnant or breastfeeding women, and children under 10 years of age. Caution is required when administering to patients with a history of alcohol dependence, impaired liver function, or decreased kidney function; regular liver and kidney function testing should be performed. This medication may cause side effects such as liver dysfunction, dyspepsia, headache, dizziness, myalgia, skin rash, and allergic reactions. If these symptoms persist or worsen, consult a healthcare professional. This medication can interact with other drugs, so inform your doctor or pharmacist of any other medications you are taking, especially those that inhibit or induce enzymes involved in drug metabolism in the liver. This medication is contraindicated during pregnancy; therefore, women of childbearing potential should use appropriate contraception while taking this medication and discontinue it immediately if pregnancy is confirmed. Breastfeeding mothers should not take this medication and should consider discontinuing breastfeeding or alternative treatments. If symptoms such as myalgia, fatigue, or fever occur while taking this drug, inform your physician immediately, and it is important to routinely check for muscle damage through blood tests. Special caution is needed when administering this medication to children and the elderly. Elderly patients are at higher risk for myopathy, hence more careful observation is necessary. In case of overdose, since there is no specific antidote, appropriate treatment should be given based on symptoms, and tests to check liver function and muscle damage may be necessary. This medication should be stored in a cool and dry place away from direct sunlight, out of the reach of children, ideally kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be kept in a sealed container. It is important to maintain a storage temperature between 1°C and 30°C. This helps preserve the drug's efficacy and safety.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Huinus Meditech Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.